Capacity Bio has filed a notice of an exempt offering of securities to raise $35,329,982.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Capacity Bio is raising $35,329,982.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Kenneth Horne played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Capacity Bio
Capacity Bio, Inc. is a therapeutics company focused on mitophagy.
To learn more about Capacity Bio, visit http://www.capacitybio.com/
Contact:
Kenneth Horne, Chief Executive Officer
650-814-1639
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.